Results 151 to 160 of about 121,700,018 (217)

Antibody-Integrated Solid-to-Gel Microfilm for Protection Against Botulinum Neurotoxin Type A. [PDF]

Gels
Ha JH, Jeon S, Lee YW, Hwang SH, Kang BH, Song YJ, Lim JS, Kim H, Yoon Y, Jeong JH.   +9 more
europepmc   +1 more source

Botulinum Neurotoxin Type A Combined with Platelet-Rich Plasma Promotes Hair Follicle Growth and Regeneration via STMN1 Modulation and Wnt/β-Catenin Pathway Activation. [PDF]

J Microbiol Biotechnol
Li J, Jia Z, Zhou Y, Gao L, Ma Y.
europepmc   +1 more source

Model-based interspecies interpretation of botulinum neurotoxin type A on muscle-contraction inhibition. [PDF]

Biopharm Drug Dispos
Ryu HJ, Kwak S, Park M, Yun HY.
europepmc   +1 more source

Botulinum Neurotoxin Type A in paediatric non-neurogenic therapy resistant overactive bladder: a cohort study. [PDF]

Int Urol Nephrol
Hougaard NB, Breinbjerg A, Kamperis K, Skott M.   +3 more
europepmc   +1 more source

Recombinant expression of receptor binding domains of all eight subtypes of botulinum neurotoxin type A for generation of antitoxins with broad reactivity. [PDF]

F1000Res
Quynh Pham N, Mai TT, Dang TBA, Huong Tran L, Mai Vu Q, Trong Nguyen C, Thi Phuong Tran A, Dang TNM, Tran VA, Huy Tran T, Tran VK, Quang Le H.   +11 more
europepmc   +1 more source

Diagnostic Nerve Block to Guide Botulinum Neurotoxin Type A Injection for Clonus in Spastic Equinovarus Foot: A Retrospective Study. [PDF]

Toxins (Basel)
Filippetti M, Tamburin S, Di Maria I, Angeli C, Di Censo R, Mantovani E, Smania N, Picelli A.   +7 more
europepmc   +1 more source

Delphi Analysis: Optimizing Anatomy Teaching and Ultrasound Training for Botulinum Neurotoxin Type A Injection in Spasticity and Dystonia. [PDF]

Toxins (Basel)
Heckert K, Biering-Sørensen B, Bäumer T, Khan O, Pagan F, Paulin M, Stitik T, Verduzco-Gutierrez M, Reebye R.   +8 more
europepmc   +1 more source

Do Diagnostic Nerve Blocks Affect the Starting Dose of Botulinum Neurotoxin Type A for Spasticity? A Case-Control Study. [PDF]

Toxins (Basel)
Filippetti M, Tamburin S, Di Censo R, Aldegheri R, Mantovani E, Spina S, Battaglia M, Baricich A, Santamato A, Smania N, Picelli A.   +10 more
europepmc   +1 more source

Consensus on the Cosmetic Use of a Novel Botulinum Neurotoxin Type A Product (NEWLUX^®) for Facial Expression Muscles: 2024 Guidelines and Discussions by Korean Experts. [PDF]

Toxins (Basel)
Rho NK, Bae GY, Choi MS, Chung WK, Kim HY, Kim HM, Lee HK, Lee YW, Oh W, Song WC.   +9 more
europepmc   +1 more source

Corrigendum: Patient Perspectives on the Therapeutic Profile of Botulinum Neurotoxin Type A in Spasticity. [PDF]

Front Neurol, 2020
Jacinto J, Varriale P, Pain E, Lysandropoulos A, Esquenazi A.   +4 more
europepmc   +1 more source